Haemodialysis Patients

Patient compliance is expected to be manageable because assessments occur during regular dialysis attendance. A dedicated colchicine trial is considered necessary because end-stage kidney disease patients were excluded from prior colchicine cardiovascular trials. Patients with end-stage kidney disease have high cardiovascular risk.